Clinical trials
Phase 2 Hemoglobinopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 2 |
| Fred Hutchinson Cancer Center | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Biossil Inc. | 1 |
| Case Western Reserve University | 1 |
| Children's Hospital of Philadelphia | 1 |
| Craig Seaman | 1 |
| Dana-Farber Cancer Institute | 1 |
| Forma Therapeutics, Inc. | 1 |
| Hillhurst Biopharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinopathies | 22 |
| Anemia, Sickle Cell | 12 |
| Thalassemia | 9 |
| Bone Marrow Failure Disorders | 6 |
| Hematologic Diseases | 6 |
| beta-Thalassemia | 6 |
| Anemia | 4 |
| Anemia, Hemolytic | 4 |
| Genetic Diseases, Inborn | 3 |
| Hemoglobin SC Disease | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.